Research Topics
| Henry C KitchenerSummaryAffiliation: Manchester Royal Infirmary Country: UK Publications
| Collaborators
|
Detail Information
Publications
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trialH C Kitchener
Division of Human Development, University of Manchester, Hathersage Road, Manchester M13 0JH, UK
Br J Cancer 95:56-61. 2006..HPV 16 and HPV 18 are more predictive of underlying disease, but other HPV types account for 30% of high-grade disease...
The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trialH C Kitchener
Division of Human Development, Academic Unit of Obstetrics and Gynaecology, University of Manchester, Manchester, United Kingdom
Int J Gynecol Cancer 18:743-8. 2008..HPV testing does not add significant psychologic distress when combined with cytology in routine primary cervical screening...
HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasiaH C Kitchener
Academic Unit of Obstetrics and Gynaecology, School of Cancer and Imaging Science, University of Manchester, Manchester, UK
BJOG 115:1001-7. 2008..To evaluate human papillomavirus (HPV) testing in combination with cytology in the follow up of treated women...
Chapter 7: Achievements and limitations of cervical cytology screeningHenry C Kitchener
Academic Unit of Obstetrics and Gynaecology, University of Manchester, St Mary s Hospital, Whitworth Park, Manchester, UK
Vaccine 24:S3/63-70. 2006..The increasing rate of human papillomavirus (HPV) testing and the prospect of prophylactic vaccination will change the way cervical cytology is used, possibly giving way to HPV testing as the primary test in secondary prevention...
Laparoscopic versus open colposuspension--results of a prospective randomised controlled trialH C Kitchener
Division of Human Development, University of Manchester, Manchester, UK
BJOG 113:1007-13. 2006..To compare the effectiveness and cost effectiveness of open and laparoscopic colposuspension in the treatment of stress urinary incontinence...
Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive womenHenry Kitchener
Academic Unit of Obstetrics and Gynaecology, University of Manchester, St Mary s Hospital, Manchester, United Kingdom
Int J Cancer 121:2484-91. 2007..Cytology appears to be sufficient for cervical surveillance, with HPV testing being less specific with poor positive predictive value. There appears to be no additional benefit from routine colposcopy...
Management of endometrial cancerH Kitchener
Academic Unit of Obstetrics and Gynaecology, University of Manchester, St Mary s Hospital, Whitworth Park, Manchester ARK, United Kingdom
Eur J Surg Oncol 32:838-43. 2006..To review broadly the diagnosis and treatment of endometrial cancer, concentrating on the evidence base...
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccinationLucy J C Smyth
Cancer Research UK Immunology Group, Paterson Institute for Cancer Research, Christie Hospital, Manchester, United Kingdom
Clin Cancer Res 10:2954-61. 2004..Other factors that may play a role in the eradication of long-term established AGIN lesions need to be determined to identify the patient group that would benefit from immunotherapy with the vaccines used in this study...
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trialHenry C Kitchener
School of Cancer and enabling Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
Eur J Cancer 47:864-71. 2011..We wished to determine, through a further (third) round of screening in the ARTISTIC trial, the protection provided by a negative baseline HPV screen compared with that of cytology over a 6 year period...
The second to fourth digit ratio (2D:4D) in women with and without human papillomavirus and cervical dysplasiaLoretta Brabin
Academic Unit of Obstetrics and Gynaecology, University of Manchester, Manchester M13 OJH, United Kingdom
Am J Hum Biol 20:337-41. 2008..A similar, nonsignificant trend was observed among women with a persistent HPV infection. CONCLUSION: Lower fetal androgen exposure may predispose to persistent HPV and increased risk of CIN...
Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteinsEmma J Davidson
Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, United Kingdom
Cancer Res 63:6032-41. 2003..Local immune infiltration may be a critical factor in potential responsiveness to vaccine therapy in HPV-associated neoplasia and should be carefully monitored in future placebo-controlled trials of immunotherapy for VIN...
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialHenry C Kitchener
School of Cancer and Imaging Sciences, University of Manchester, Manchester, UK
Lancet Oncol 10:672-82. 2009....
Human papillomavirus in cervical screening and vaccinationEmma J Crosbie
Academic Unit of Obstetrics and Gynaecology, University of Manchester, St Mary's Hospital, Whitworth Park, Manchester M13 0JH, UK
Clin Sci (Lond) 110:543-52. 2006..For those generations of women already exposed to high-risk HPV infection, therapeutic vaccines may offer advantages over conventional treatment, although much work still needs to be done...
Human papillomavirus as a target for management, prevention and therapyEmma J Crosbie
Academic Unit of Obstetrics and Gynaecology, University of Manchester, St Mary s Hospital, Manchester, UK
Int J Hyperthermia 28:478-88. 2012..In this review, the latest evidence supporting HPV as both a biomarker of risk for cervical cancer and a target for prophylactic and therapeutic vaccination is presented...
Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trialEmma J Crosbie
Gynaecology Oncology Research Group, School of Cancer and enabling Sciences, University of Manchester, Manchester, UK
Eur J Cancer 48:853-64. 2012....
A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consentLoretta Brabin
Academic Unit of Obstetrics and Gynaecology, Research Floor, St, Mary s Hospital, Whitworth Park, Manchester, M13 0JH, UK
BMC Public Health 7:20. 2007..Under-16s in the UK have a right to confidential sexual health care without parental consent. We investigated parents' views on making available HPV vaccination to adolescent minors at sexual health clinics without parental consent...
Informing adolescents about human papillomavirus vaccination: what will parents allow?Lorraine A Vallely
Academic Unit of Obstetrics and Gynaecology, University of Manchester, M13 OJH, United Kingdom
Vaccine 26:2203-10. 2008..Our results indicated that the film's four key messages were acceptable to parents and largely understood by adolescents but these messages will need reinforcing if the full potential of a prophylactic vaccine is to be realised...
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasiaUrsula Winters
School of Cancer and Imaging, University of Manchester, St Mary s Hospital, Immunology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom
Clin Cancer Res 14:5292-9. 2008..Indeed, there is evidence that immunosuppressed individuals have higher rates of VIN, suggesting immune control is relevant...
Five-year follow-up of women with borderline and mildly dyskaryotic cervical smearsD N Rana
Manchester Cytology Centre, Manchester Royal Infirmary, Manchester M13 9WW, UK
Cytopathology 15:263-70. 2004....
Therapy of human papillomavirus-related diseasePeter L Stern
Paterson Institute for Cancer Research, University of Manchester, Manchester M20 4BX, UK
Vaccine 30:F71-82. 2012..This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012...
To stage or not to stage? That is the question: (with apologies to Shakespeare)Henry C Kitchener
University of Manchester, Manchester, UK
Int J Gynecol Cancer 20:S55-6. 2010..Until new trial evidence is produced to the contrary, routine lymphadenectomy cannot be recommended for endometrial cancer...
Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudesLoretta Brabin
Academic Unit of Obstetrics and Gynaecology, University of Manchester, Manchester, M13 OJH, UK
Vaccine 24:3087-94. 2006..It will be important to raise general awareness of the role of HPV in cervical cancer without stigmatizing the vaccine...
Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trialHenry C Kitchener
School of Cancer and enabling Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
Lancet Oncol 12:56-64. 2011..In the Manual Assessment Versus Automated Reading In Cytology (MAVARIC) trial, we compared the accuracy of these techniques for the detection of underlying disease...
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysisEmma J Crosbie
Gynaecology Oncology Research Group, School of Cancer and enabling Sciences, University of Manchester, Manchester, UK
Cancer Epidemiol Biomarkers Prev 19:3119-30. 2010..Body mass index (BMI) is a risk factor for endometrial cancer. We quantified the risk and investigated whether the association differed by use of hormone replacement therapy (HRT), menopausal status, and histologic type...
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trialA Sargent
Division of Cancer Studies and Imaging, University of Manchester, Hathersage Road, Manchester M13 0JH, UK
Br J Cancer 98:1704-9. 2008..In the absence of broader cross-protection, the large majority of low-grade and many high-grade abnormalities may still occur in sexually active vaccinated women...
Cervarix--a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancerEmma J Crosbie
University of Manchester, Academic Unit of Obstetrics and Gynaecology, St Mary s Hospital, Whitworth Park, Manchester, M13 0JH, UK
Expert Opin Biol Ther 7:391-6. 2007..The clinical experience of Cervarix and its potential role in reducing the global burden of cervical cancer is discussed...
ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screeningH C Kitchener
School of Cancer and Imaging Sciences, University of Manchester, St Mary s Hospital, Manchester, UK
Health Technol Assess 13:1-150, iii-iv. 2009..CIN3+?; Is HPV testing cost-effective in primary cervical screening?; Is its use associated with adverse psychosocial or psychosexual effects?; and How would it perform as an initial screening test followed by cytology for HPV positivity?..
A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smearsH C Kitchener
Academic Unit of Obstetrics and Gynaecology, St Mary's Hospital, Manchester, UK
BJOG 111:63-70. 2004..If a patient is anxious, allowing the patient to choose immediate colposcopy may be preferable because it will improve ascertainment of underlying disease in a group who are more likely to default...
Endometrial cancer state of the science meetingHenry C Kitchener
UK National Cancer Research Institute and University of Manchester, Manchester, United Kingdom
Int J Gynecol Cancer 19:134-40. 2009..To identify the most important trials for women with endometrial carcinoma and uterine carcinosarcoma, both those already underway or to be done, for which the Gynecological Cancer Intergroup might facilitate international cooperation...
The use of vaccines in the prevention and treatment of cervical cancerEmma J Davidson
Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK
Clin Oncol (R Coll Radiol) 14:193-200. 2002..A papillomavirus vaccine that prevented HPV infection on the one hand and acted against established disease on the other, would have a profound impact on one of the major cancers affecting women globally...
No alteration in NK function or zeta chain expression in NK and T cells of cervical cancer patientsToli S Onon
Department of Immunology, Paterson Institute for Cancer Research, Christie Hospital, Manchester, United Kingdom
Gynecol Oncol 89:120-8. 2003..To investigate in vitro natural killer (NK) cell activity and expression of signal-transducing zeta chains in patients with cervical cancer...
Biological and hormonal markers of chlamydia, human papillomavirus, and bacterial vaginosis among adolescents attending genitourinary medicine clinicsL Brabin
Academic Unit of Obstetrics and Gynaecology and Reproductive Health Care, Research Floor, St Mary s Hospital, Whitworth Park, Manchester M13 0JH, UK
Sex Transm Infect 81:128-32. 2005..To assess maturity indices, menstrual patterns, hormonal factors, and risk of adolescent genital tract infections...
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapyE S Abdel-Hady
University of Manchester, Academic Department of Obstetrics and Gynaecology and Reproductive Health Care, St. Mary's Hospital, United Kingdom
Cancer Res 61:192-6. 2001..0001). These data clearly support the contention that high-risk HPV infection and lack of cell-mediated immunity may play a role in the observed poor response of lower genital lesions to topical PDT...
The IL-10 -1082G polymorphism is associated with clearance of HPV infectionF Farzaneh
Academic Unit of Obstetrics and Gynaecology, St Mary s Hospital, Manchester, UK
BJOG 113:961-4. 2006..028 [95% CI 0.001-0.66], P= 0.001). This preliminary study suggests that higher levels of IL-10 may prevent cervical neoplasia through their role in eliminating HPV...
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7)E J Davidson
Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK
Vaccine 22:2722-9. 2004..Three patients additionally showed lesion shrinkage or symptom relief, but no direct correlation between clinical and immunological responses was seen...
Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer centerR E Board
Cancer Research UK Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom
Int J Gynecol Cancer 16:18-24. 2006..Further clinical trials are needed to test whether combinations of surgical, histologic, biochemical, and radiologic parameters can be used to identify a population with such a good prognosis that adjuvant therapy is not required...
Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinicsL Brabin
Academic Unit of Obstetrics and Gynaecology and Reproductive Health Care, Research Floor, St Mary s Hospital, Whitworth Park, Manchester M13 0JH, UK
Sex Transm Infect 81:483-7. 2005..We assessed hormonal factors and risk of abnormal vaginal pH and bacterial vaginosis (BV) among adolescents attending genitourinary medicine (GUM) clinics...
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancerAndreas M Kaufmann
Frauenklinik, Friedrich Schiller University of Jena, 07743 Jena, Germany
Clin Cancer Res 8:3676-85. 2002....
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screeningPhilip Davies
European Cervical Cancer Association, 68 cours Albert Thomas, Lyon, France
Int J Cancer 118:791-6. 2006..Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test...
Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British womenEmma J Davidson
Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester M20 4BX, United Kingdom
Cancer Res 63:400-3. 2003..Such factors are important to the development of HPV vaccines for treatment of cervical and vulval neoplasia...
Cervical regeneration after diathermy excision of cervical intraepithelial neoplasia as assessed by transvaginal sonographyEvangelos Paraskevaidis
Department of Obstetrics and Gynecology, University of Ioannina, Ioannina, Greece
Eur J Obstet Gynecol Reprod Biol 102:88-91. 2002..To evaluate regeneration in cervical craters following large loop excision of the transformation zone (LLETZ) and to investigate possible differential healing patterns depending on the cone's size...
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialJorma Paavonen
University of Helsinki, Department of Obstetrics and Gynaecology, Helsinki, Finland
Lancet 369:2161-70. 2007....
Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasiaEmma J Davidson
Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
J Gen Virol 84:2089-97. 2003..In spite of previous studies showing the immunogenicity of E2 in eliciting primary T-cell responses in vitro, there was a low prevalence of E2 responses in the VIN patients and controls (2/18 vs 0/17)...
